Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer

NCT02646228 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02646228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02646228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 4, 2016
Completion date
June 30, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer